VerticalNews VerticalNews
VerticalNews VerticalNews VerticalNews VerticalNews     VerticalNews VerticalNews

VerticalNews
Government
Technology
Science
International
Business
Ecology & Environment
Entertainment
Education
VerticalNews
VerticalNews
VerticalNews
VerticalNews

VerticalNews Ivy League

Welcome to VerticalNews!

RECEIVE OUR FREE NEWSLETTER
ON IVY LEAGUE

We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.

Buy Now



Business News



Anthera Pharmaceuticals Announces Pricing of $31.5 Million PIPE Financing



October 5th, 2010

Anthera Pharmaceuticals, Inc. (Nasdaq: ANTH), announced that it has entered into definitive agreements with certain accredited investors in connection with a private placement, or PIPE, financing transaction pursuant to Section 4(2) of the Securities Act of 1933, as amended, and Regulation D promulgated thereunder. Upon the closing of the transaction, Anthera will receive gross proceeds of approximately $31.5 million in exchange for the issuance to such investors of 10,500,000 units, with each unit consisting of one share of Anthera common stock and one warrant to purchase 0.40 shares of Anthera common stock. The warrants will be exercisable for a period of five years from the date of their...

Click here for more articles from Business News


Source: VerticalNews Ivy League (2010-10-05)

VerticalNews
VerticalNews

VerticalNews
SSL VerticalNews